
© 2024 Der Aktionär
Realtime | Geld | Brief | Zeit |
---|---|---|---|
277,75 | 278,30 | 25.04. | |
278,30 | 279,25 | 25.04. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
00:18 | Gilead Sciences CDR (CAD Hedged): Gilead Sciences CDR to trade on Cboe Canada | ||
Fr | Why Gilead Sciences Stock Slipped Today | ||
Fr | Gilead leans on HIV drugs as oncology sales slow | ||
Fr | Gilead, 'closely attuned to' potential US policy shifts, stands by long-acting PrEP launch | ||
Fr | Gilead Sciences Stock Falls as Slumping COVID-19, Cancer Drug Sales Hit Revenue |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | McDonald's Bets on Chicken for First New Permanent Item in 4 Years, but Fans Are Still Looking for Snack Wraps | ||
Fr | McCrispy Strips Mark A New Era For McDonald's Everyday Menu | ||
Do | Dow Jones Fast Food Giant McDonald's Leads Restaurant Group Higher | ||
Do | McDonald's bringt McCrispy Strips zurück auf die Speisekarte | ||
Do | McDonald's is adding its first new permanent addition to its menu in four years |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | Salesforce Inc (CRM): Among Billionaire Steve Cohen's Large-Cap Stock Picks With Huge Upside Potential | ||
Fr | WithSecure Q1 2025 slides: Salesforce protection drives growth amid European pivot | ||
Fr | Needham maintains Buy rating, $400 target on Salesforce stock | ||
Fr | WithSecure Oyj: WithSecure Interim Report 1 January - 31 March 2025: Elements ARR growth continued, 70% ARR growth for Cloud Protection for Salesforce | WithSecure Corporation, Interim Report 1 January - 31 March 2025, 25 April 2025 at 8.00 EEST WithSecure Interim Report 1 January - 31 March 2025: Elements ARR growth continued, 70% ARR growth for... ► Artikel lesen | |
Do | Salesforce setzt auf KI: Chancen und Risiken der neuen Strategie |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Mo | Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost | ||
Mo | Piper Sandler cuts Sarepta stock target to $110 on Elevidys concerns | ||
16.04. | SRPT Provides Pipeline Updates on Rare Muscular Disorder Therapies | ||
11.04. | Sarepta initiated with a bullish view at Wells Fargo on Elevidys | ||
11.04. | Wells Fargo sets Sarepta stock price target at $115 |
Unternehmen / Aktien | Kurs | % |
---|---|---|
GILEAD SCIENCES INC | 91,49 | +0,75 % |
MCDONALDS CORPORATION | 278,50 | -0,09 % |
SALESFORCE INC | 235,25 | -0,25 % |
SAREPTA THERAPEUTICS INC | 54,00 | +1,43 % |